跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Kotamir - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Kotamir
Approved
STANDARD
Kotamir
Azarias Pharmaceutical Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a3e7f8dbb5c8d218
Company
Azarias Pharmaceutical Laboratories Inc.
Type
Standard
Approval Details
Approval Id
a3e7f8dbb5c8d218
Drug Approval Philippines Name
Kotamir
Product Name
Kotamir
Registration Number
DRP-8637-10
Brand Name
Kotamir
Generic Name
Butamirate citrate
Dosage Form
Sustained-Release Tablet
Dosage Strength
50 mg
Manufacturer
Azarias Pharmaceutical Laboratories Inc.
Distributor
Konzept Convenience and Drug Store Corp
Issuance Date
24 February 2025
Expiry Date
05 September 2050
Pharmacologic Category
Antitussives
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a3e7f8dbb5c8d218
Type
Standard
Back to Philippines FDA Approvals